Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL-56 in IgA Nephropathy
NCT00767221Phase 2Completed
- Sponsor
- Calliditas Therapeutics AB
- Start
- Oct 2005
- Primary completion
- Nov 2008
- Countries
- 1
01
Overview
A Phase 2 trial of nefecon in IgA nephropathy (IgAN), sponsored by Calliditas Therapeutics AB. Started Oct 2005; status: completed.
02
Drugs
nefecon
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00767221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767221.